This week, UnitedHealth ( UNH) hopes to shift investors' focus from its CEO's profits to the company's own.The giant health insurer -- long considered the industry bellwether -- looks poised to deliver another strong quarterly report on Wednesday morning. Wall Street expects the Minnetonka, Minn., company to make 68 cents a share, up from 61 cents a year earlier, according to Thomson Financial. Analysts expect revenue, lifted by a major acquisition, to surge 61% from a year ago to $17.9 billion. A strong showing could soothe investors who have grown nervous about the sector. But even solid results may fail to calm those who have been dwelling on the controversial stock option grants that reportedly handed CEO William McGuire some $1.6 billion in unrecognized stock option gains. "Unless it can resolve the options issues between now and July 19, second-quarter results probably won't have much of an impact on the company's stock price," CIBC analyst Carl McDonald wrote earlier this month. "We think the stock is likely to be range-bound until the options controversy is put to rest." Sheryl Skolnick, senior vice president of CRT Capital Group, agrees, though she adds that investors will still be watching enrollment and pricing trends. "What we learned from last quarter was that, if you miss your enrollment targets, your stock goes down 2% to 5%," Skolnick notes. "But if your pricing looks aggressive -- let alone irrational -- your stock goes down 25%. ... So I think there is a lot of twitchiness about the industry this quarter." UnitedHealth stock, which peaked above $64 late last year, rose 13 cents Monday to $47.68.